Patients Say Ketogenic Diet Aids Multiple Sclerosis Symptoms
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 21, 2023 -- Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition.
Emma Wetmore, from University of Virginia in Charlottesville, and colleagues evaluated patient perceptions of the KD. The analysis included three-month follow-up from 52 participants with relapsing MS previously enrolled in a prospective six-month KD trial.
The researchers found that 21 percent of participants reported continued adherence to a strict KD, while 37 percent reported adhering to a liberalized, less restrictive form of the KD. At the end of the trial, participants with greater reductions in body mass index and fatigue while on the diet were more likely to continue on KD. Patient-reported and clinical outcomes at three months posttrial remained significantly improved from baseline (pre-KD), although the degree of improvement was slightly attenuated compared with outcomes at six months on KD. Dietary patterns shifted toward greater protein and polyunsaturated fats and less carbohydrate and added sugar consumption, regardless of diet type after the KD trial. Nearly half of participants believed the KD benefited MS symptoms (e.g., paresthesias, numbness, balance, and headaches), and nearly one-quarter of participants (23 percent) were able to reduce and/or discontinue previously prescribed medications that had been used for symptomatic treatment.
"This post-trial observational study provides evidence that KDs are sustainable diets (in the short term) outside of the clinical trial setting," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Peanut Consumption Starting in Infancy Provides Lasting Tolerance
THURSDAY, May 30, 2024 -- Peanut consumption starting in infancy and continuing to age 5 years provides lasting tolerance into adolescence, according to a study published in the...
High Mediterranean Diet Adherence Tied to Fewer Anxiety, Stress Symptoms
FRIDAY, May 24, 2024 -- Adherence to a Mediterranean diet (MedDiet) is inversely associated with the severity of anxiety and stress symptoms in older adults, according to a study...
Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children
WEDNESDAY, May 22, 2024 -- High ultraprocessed food (UPF) consumption in young children is associated with adiposity and other cardiometabolic risk factors, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.